» Articles » PMID: 38199635

Extended Pancreatic Neck Transection Versus Conventional Pancreatic Neck Transection During Laparoscopic Pancreaticoduodenectomy (LPDEXCEPT): Protocol for a Multicentre Superiority Randomised Controlled Trial

Overview
Journal BMJ Open
Specialty General Medicine
Date 2024 Jan 10
PMID 38199635
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Postoperative pancreatic fistula (POPF) remains one of the most severe complications of laparoscopic pancreaticoduodenectomy (LPD). Theoretically, transecting the pancreatic neck more distally has both advantages (more blood supply, and more central pancreatic duct) and disadvantages (maybe smaller the pancreatic duct) in preventing POPF. This theoretical contradiction pushed us to organise this trial to explore the impact of the level of pancreatic transection in clinical practice. We conduct this randomised trial with the hypothesis that extended pancreatic neck transection has superiority to conventional pancreatic neck transection.

Methods And Analysis: The LPDEXCEPT (Extended pancreatic neck transection versus conventional pancreatic neck transection during laparoscopic pancreaticoduodenectomy) trial is a multicentre, randomised-controlled, open-label, superiority trial in 4 centres whose annual surgical volume for LPD is more than 25 cases with pancreatic surgeons who had completed their learning curve. A total of 154 patients who meet the inclusive and exclusive criteria are randomly allocated to the extended pancreatic neck transection group or conventional pancreatic neck transection group in a 1:1 ratio. The stratified randomised block design will be applied, with stratified factors are surgical centre and the diameter of the main pancreatic duct measured by preoperative CT scan (preMPD). The primary outcome is the incidence of the clinically relevant pancreatic fistula.

Ethics And Dissemination: Ethics Committee on Biomedical Research of West China Hospital of Sichuan University has approved this trial in March 2023 (approval no. 2023-167). Results of this trial will be published in peer-reviewed journals and conference proceedings.

Trial Registration Number: NCT05808894.

References
1.
Uijterwijk B, Kasai M, Lemmers D, Chinnusamy P, van Hilst J, Ielpo B . The clinical implication of minimally invasive versus open pancreatoduodenectomy for non-pancreatic periampullary cancer: a systematic review and individual patient data meta-analysis. Langenbecks Arch Surg. 2023; 408(1):311. PMC: 10427526. DOI: 10.1007/s00423-023-03047-4. View

2.
Budzynski J, Tojek K, Czerniak B, Banaszkiewicz Z . Scores of nutritional risk and parameters of nutritional status assessment as predictors of in-hospital mortality and readmissions in the general hospital population. Clin Nutr. 2016; 35(6):1464-1471. DOI: 10.1016/j.clnu.2016.03.025. View

3.
Klompmaker S, van Hilst J, Wellner U, Busch O, Coratti A, DHondt M . Outcomes After Minimally-invasive Versus Open Pancreatoduodenectomy: A Pan-European Propensity Score Matched Study. Ann Surg. 2018; 271(2):356-363. DOI: 10.1097/SLA.0000000000002850. View

4.
Schuh F, Mihaljevic A, Probst P, Trudeau M, Muller P, Marchegiani G . A Simple Classification of Pancreatic Duct Size and Texture Predicts Postoperative Pancreatic Fistula: A classification of the International Study Group of Pancreatic Surgery. Ann Surg. 2021; 277(3):e597-e608. PMC: 9891297. DOI: 10.1097/SLA.0000000000004855. View

5.
Sattari S, Sattari A, Makary M, Hu C, He J . Laparoscopic Versus Open Pancreatoduodenectomy in Patients With Periampullary Tumors: A Systematic Review and Meta-analysis. Ann Surg. 2022; 277(5):742-755. DOI: 10.1097/SLA.0000000000005785. View